PKM and Patent ductus arteriosus: Alternative splicing of the pyruvate kinase gene was differentially modulated in GEM-resistant PDA cells, resulting in the promotion of the PKM2 isoform, whose expression correlated with short recurrence and disease-free survival in patients [98].